Inventor · disambiguated record
Ravi Chari
Also filed as: CHARI RAVI · CHARI RAVI J
10 granted patents·8 pending applications·3,695 citations·filing 1992–2022
92Inventor score
Top patents by PatentIndex Score
18 records- 0198US5416064ACytotoxic agents comprising maytansinoids and their therapeutic useIMMUNOGEN INC·Filed 1992·Granted May 16, 1995·1.3k cites·20 claims
- 0298US5208020ACytotoxic agents comprising maytansinoids and their therapeutic useIMMUNOGEN INC·Filed 1992·Granted May 4, 1993·2.4k cites·18 claims
- 0389US9670276B2IL-1 binding proteinsABBVIE INC·Filed 2013·Granted Jun 6, 2017·15 cites·24 claims
- 0489US9045551B2Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereofABBVIE INC·Filed 2014·Granted Jun 2, 2015·12 cites·11 claims
- 0588US9505829B2Anti-NGF antibodies and their useLACY SUSAN E·Filed 2011·Granted Nov 29, 2016·14 cites·13 claims
- 0684US9944720B2Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereofABBVIE INC·Filed 2015·Granted Apr 17, 2018·4 cites·13 claims
- 0783US10125192B2Caninized anti-NGF antibodies and their useZOETIS BELGIUM S A·Filed 2015·Granted Nov 13, 2018·5 cites·4 claims
- 0883US10093725B2Anti-NGF antibodies and their useZOETIS BELGIUM S A·Filed 2015·Granted Oct 9, 2018·5 cites·4 claims
- 0981US9163093B2Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereofGU JIJIE·Filed 2013·Granted Oct 20, 2015·5 cites·18 claims
- 1076US2022403052A1Anti-dll4/vegf dual variable domain immmunoglobulin and uses thereofABBVIE INC·Filed 2022·Application pending·0 cites
- 1173US9840554B2Antibodies against platelet-derived growth factor (PDGF)ABBVIE INC·Filed 2016·Granted Dec 12, 2017·2 cites·9 claims
- 1260US2020385456A1Stable Dual Variable Domain Immunoglobulin Protein FormulationsABBVIE INC·Filed 2020·Application pending·0 cites
- 1360US2019031783A1Anti-dll4/vegf dual variable domain immunoglobulin and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1456US2018362629A1Anti-ngf antibodies and their useZOETIS BELGIUM S A·Filed 2018·Application pending·0 cites
- 1555US2021188996A1Formulations of anti-cd38 antibodies for subcutaneous administrationSANOFI AVENTIS US LLC·Filed 2020·Application pending·0 cites
- 1651US2014161817A1Stable dual variable domain immunoglobulin protein formulationsSIEDLER MICHAEL·Filed 2013·Application pending·0 cites
- 1748US2017210796A1Stable Dual Variable Domain Immunoglobulin Protein FormulationsABBVIE INC·Filed 2016·Application pending·0 cites
- 1834US2011256135A1Anti-nerve growth factor (ngf) antibody compositionsFRAUNHOFER WOLFGANG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ravi Chari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →